In an attempt to correlate the growth-inhibitory activity of SR31747A with the presence of its receptors, we evaluated EBP and SR-BP expression levels by flow cytometry using specific antibodies in the breast and prostatic cancer cell lines used in this study. This evidence concerns the gene EBP and prostate carcinoma.